According to the Summary of Product Characteristics (SmPC), the most common side effects include: Nausea (affecting 12-24% of patients, with frequency increasing at higher doses) Diarrhoea (reported in 13-22% of participants) Vomiting (occurring in 6-10% of patients) Constipation (affecting 5-12% of users) Abdominal pain or discomfort Dyspepsia (indigestion) Decreased appetite These effects are typically mild to moderate in severity and tend to diminish over time as the body adjusts to treatment
Tirzepatide does not cause dehydration directly in the way a diuretic would
Some of the GLP-1 medications may not be covered by insurance
Ongoing All Active Therapy Phases Protein Optimisation Use FFM, Not Body Weight: Protein targets calculated from total body weight are inaccurate in overweight patients
A lipotropic compound blend containing L-Carnitine, L-Arginine, Methionine, Inositol, Choline, Vitamin B5, Vitamin B6, and Vitamin B12 for analytical, biochemical, metabolic pathway, nutrient transport, and methylation-related research contexts